Get startedLog in
    Picture of S Biomedics Co logo

    304360 — S Biomedics Co Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for S Biomedics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSAnnual Audited Accounts
    Standards:————
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue5,0145,3198,86812,11313,108
    Cost of Revenue
    Gross Profit9611,2984,3196,1116,554
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses14,08813,75213,47415,85619,062
    Operating Profit-9,075-8,433-4,606-3,744-5,954
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-9,015-8,594-5,249-5,210-6,337
    Provision for Income Taxes
    Net Income After Taxes-9,013-8,590-5,242-4,755-6,460
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-8,098-7,747-5,667-6,327-7,524
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-8,098-7,747-5,667-6,327-7,524
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-737-705-517-576-691
    Dividends per Share